Market Overview
The global nucleic acid therapeutics CDMO market size was valued at USD 1,908.41 million in 2022. It is estimated to reach USD 4,917.52 million by 2031, growing at a CAGR of 11.09% during the forecast period (2023–2031).
The global Nucleic Acid Therapeutics CDMO market continues to evolve rapidly, driven by shifting consumer trends, rising...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek